Case | HBS Case Collection | 2012 (Revised from original 2012 version)
by Ananth Raman, Inga Maurer and William Schmidt
Merck is known for its commitment to investing in basic R&D. Are Merck's long-term investments justifiable when the firm faces extreme earnings pressure?
Keywords: Science-Based Business; Management; Research and Development; Business and Shareholder Relations; Operations; Pharmaceutical Industry; United States;
Citation:
Raman, Ananth, Inga Maurer, and William Schmidt. "Merck: Operating Science-Based Business." Harvard Business School Case 612-082, May 2012. (Revised from original April 2012 version.)
Case | HBS Case Collection | 2010
Merck: Investing in Science-Based Business (Abridged)
Ananth Raman and Inga Katharina Maurer
Keywords: Factories, Labs, and Plants; Cost Management; Production; Research and Development;
View Profile »View Publications »
Background Note | HBS Case Collection | 2013 (Revised from original 2012 version)
Inventory-Based Lending Industry Note
C. Fritz Foley, Ananth Raman and Nathan C. Craig
Keywords: Banks and Banking; Financing and Loans; Banking Industry;
Working Paper | HBS Working Paper Series | 2013
Improving Store Liquidation
Nathan Craig and Ananth Raman
Article | Harvard Business Review | May 2013
Health Care's Service Fanatics: How the Cleveland Clinic Leaped to the Top of the Patient-satisfaction Surveys
James Merlino and Ananth Raman